Castelnovo, Giovanni
Gerlach, Oliver
Freedman, Mark S.
Bergmann, Arnfin
Sinay, Vladimiro
Castillo-Triviño, Tamara
Kong, George
Koster, Thijs
Williams, Heather
Gafson, Arie R.
Killestein, Joep
Clinical trials referenced in this document:
Documents that mention this clinical trial
Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study
https://doi.org/10.1007/s40263-021-00840-x
Funding for this research was provided by:
Biogen
Article History
Accepted: 22 June 2021
First Online: 28 July 2021
Declarations
:
: This study was funded by Biogen, Cambridge, MA, USA. Open access fee funded by Biogen.
: Giovanni Castelnovo has received research/educational grants from Allergan, Biogen, Merz, and Novartis, and speaking/consulting fees from Allergan, Biogen, Ipsen, Merck, Merz, Novartis, and Sanofi-Genzyme. Mark S. Freedman has received research/educational grants from EMD (Canada), Roche, and Sanofi-Genzyme (Canada); consulting fees from Actelion (Janssen/J&J), Alexion, Biogen, Celgene (BMS), EMD, Merck Serono, Novartis, Roche, Sanofi-Genzyme, and Teva Canada Innovation; advisory board/board of directors/similar group for Actelion (Janssen/J&J), Alexion, Atara Biotherapeutics, Bayer, Biogen, Celgene (BMS), Clene Nanomedicine, GRI Bio, Magenta Therapeutics, Merck Serono, MedDay, Novartis, Roche, Sanofi-Genzyme, and Teva Canada Innovation; and speaker bureaus for EMD Serono and Sanofi-Genzyme. Vladimiro Sinay has received reimbursement for developing educational presentations, educational/research grants, and consultation fees/travel stipends from Bayer, Biogen, Biosidus, Gador, Genzyme, Merck, Novartis, Raffo/Asofarma, and Roche. Tamara Castillo-Triviño has received speaking/consulting fees and/or travel funding from Bayer, Biogen, Merck, Novartis, Roche, Sanofi-Genzyme, and Teva. Joep Killestein has received speaking/consulting fees from Biogen, Merck, Novartis, Roche, Sanofi-Genzyme, and Teva. George Kong, Thijs Koster, Heather Williams and Arie R. Gafson are employees of, and hold stock/stock options in, Biogen. Oliver Gerlach and Arnfin Bergmann have no disclosures to declare.
: Data supporting this article can be requested via the corresponding author.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. LIBERATE was registered at ClinicalTrials.gov (NCT01480063).
: Informed consent was obtained from all individual participants included in this study.
: Not applicable.
: All authors were involved in critically reviewing the manuscript for intellectual content, and have read and provided approval of the final submitted version.